CY2043A - Synthetic antigens for the detection of antibodies to hepatitis c virus - Google Patents

Synthetic antigens for the detection of antibodies to hepatitis c virus

Info

Publication number
CY2043A
CY2043A CY204398A CY204398A CY2043A CY 2043 A CY2043 A CY 2043A CY 204398 A CY204398 A CY 204398A CY 204398 A CY204398 A CY 204398A CY 2043 A CY2043 A CY 2043A
Authority
CY
Cyprus
Prior art keywords
detection
antibodies
hcv
hepatitis
virus
Prior art date
Application number
CY204398A
Other languages
English (en)
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26125651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2043(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of CY2043A publication Critical patent/CY2043A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY204398A 1990-12-14 1998-02-20 Synthetic antigens for the detection of antibodies to hepatitis c virus CY2043A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG1996005024A SG47062A1 (en) 1990-12-14 1990-12-14 Synthetic antigens for the detection of antibodies to hepatitis virus
EP90124241A EP0489968B1 (de) 1990-12-14 1990-12-14 Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus

Publications (1)

Publication Number Publication Date
CY2043A true CY2043A (en) 1998-02-20

Family

ID=26125651

Family Applications (2)

Application Number Title Priority Date Filing Date
CY204398A CY2043A (en) 1990-12-14 1998-02-20 Synthetic antigens for the detection of antibodies to hepatitis c virus
CY9802053A CY2053B1 (en) 1990-12-14 1998-04-30 Synthetic antigens for the detection of antibodies to hepatitis c virus

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY9802053A CY2053B1 (en) 1990-12-14 1998-04-30 Synthetic antigens for the detection of antibodies to hepatitis c virus

Country Status (18)

Country Link
US (1) US5922532A (de)
EP (3) EP0644202B1 (de)
JP (1) JP2995216B2 (de)
KR (3) KR0181344B1 (de)
AT (3) ATE185350T1 (de)
AU (1) AU652013B2 (de)
BR (1) BR9106220A (de)
CY (2) CY2043A (de)
DE (2) DE69030124T2 (de)
DK (3) DK0754704T3 (de)
ES (3) ES2101388T3 (de)
GR (3) GR3022089T3 (de)
HK (1) HK57597A (de)
HU (1) HU218357B (de)
IL (1) IL100158A (de)
NZ (1) NZ240964A (de)
SG (1) SG47062A1 (de)
WO (1) WO1992010514A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
DK0770679T4 (da) * 1990-11-03 2010-05-10 Siemens Healthcare Diagnostics HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
US5910404A (en) * 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
AU1459792A (en) * 1991-01-14 1992-08-27 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
KR0185426B1 (ko) * 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
US5811246A (en) * 1991-12-17 1998-09-22 The Research Foundation Of State University Of New York Process for immobilization onto the surfaces of ELISA plates of a compound carrier complex and for immunization
ZA928954B (en) * 1991-12-24 1993-05-19 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-A, non-B virus.
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
ES2287969T3 (es) 1992-03-06 2007-12-16 Innogenetics N.V. Peptidos de vih.
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
KR100317509B1 (ko) * 1992-07-16 2002-02-20 야스모토 토루 C형간염바이러스를분류하기위한항원성펩티드,이펩티드를포함하는키트및이펩티드를사용하는c형간염바이러스를분류하는방법
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
US6762024B2 (en) 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
IT1270941B (it) * 1993-05-12 1997-05-26 Sorin Biomedica Spa Peptidi di hcv e loro usi.
US7070790B1 (en) * 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
WO1996034013A1 (en) * 1995-04-28 1996-10-31 Srl, Inc. Antigen peptide compound and immunoassay method
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
WO2002004484A2 (en) * 2000-07-07 2002-01-17 Medmira Inc. Hcv mosaic antigen composition
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
US20080227111A1 (en) 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
ES2303496B1 (es) * 2008-02-21 2009-07-07 Fundacion Para El Estudio De Las Hepatitis Virales Metodo analitico perfeccionado para la deteccion de hepatitis c oculta, aplicaciones del mismo y su correspondiente kit de diagnostico.
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
FR2987836A1 (fr) * 2012-03-09 2013-09-13 Biomerieux Sa Peptides d'interference et procede de detection de microorganismes
CN114858907B (zh) * 2021-02-04 2025-02-18 北京毅新博创生物科技有限公司 用于诊断新冠病毒感染的质谱模型的构建方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US594854A (en) * 1897-12-07 Territory
US505611A (en) * 1893-09-26 Henry v
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4749259A (en) * 1987-05-15 1988-06-07 Hughes Aircraft Company Liquid crystal image projection with multicolor prepolarizing system
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
WO1989004669A1 (en) * 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
EP0445801A3 (en) * 1990-03-08 1992-07-01 Kuraray Co., Ltd. Peptide and its use
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
KR100206150B1 (ko) * 1990-04-04 1999-07-01 로버트 피. 블랙버언 항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체
AU660925B2 (en) * 1990-04-06 1995-07-13 Genelabs Technologies, Inc. Hepatitis C virus epitopes
AU635124B2 (en) * 1990-04-16 1993-03-11 United Biomedical Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
WO1992001714A1 (fr) * 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Antigene du virus de l'hepatite non a, non b
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
ATE346302T1 (de) * 1990-08-25 2006-12-15 Bioprocess Pty Ltd Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren.
JP2949822B2 (ja) * 1990-10-03 1999-09-20 住友化学工業株式会社 熱可塑性樹脂組成物
DK0770679T4 (da) * 1990-11-03 2010-05-10 Siemens Healthcare Diagnostics HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
EP0485209A1 (de) * 1990-11-08 1992-05-13 Immuno Japan Inc. Mit Non-A Non-B Hepatitis Virus verwandtes Antigen, Aufspürsysteme für Antikörper, Polynukleotide und Polypeptide
EP0516859A1 (de) * 1990-11-29 1992-12-09 Toray Industries, Inc. Non-a non-b hepatitisvirus-antigenprotein
IE65424B1 (en) * 1991-03-01 1995-10-18 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-A non-B virus
AU2068992A (en) * 1991-08-02 1993-02-04 Akzo N.V. Non-a, non-b peptide
ZA927243B (en) * 1991-10-07 1994-01-26 Akzo Nv Non-A, Non-B peptides
ES2287969T3 (es) * 1992-03-06 2007-12-16 Innogenetics N.V. Peptidos de vih.

Also Published As

Publication number Publication date
SG47062A1 (en) 1998-03-20
NZ240964A (en) 1992-10-28
AU652013B2 (en) 1994-08-11
EP0489968B1 (de) 1996-11-06
JP2995216B2 (ja) 1999-12-27
EP0754704A3 (de) 1997-05-28
GR3023664T3 (en) 1997-09-30
IL100158A (en) 1998-02-22
WO1992010514A3 (en) 1992-08-20
KR0181343B1 (ko) 1999-04-01
ES2138784T3 (es) 2000-01-16
KR0181345B1 (ko) 1999-04-01
EP0754704B1 (de) 1999-10-06
WO1992010514A2 (en) 1992-06-25
GR3032150T3 (en) 2000-04-27
ES2095852T3 (es) 1997-03-01
HUT65930A (en) 1994-07-28
DK0489968T3 (da) 1997-03-24
HK57597A (en) 1997-05-09
JPH05503722A (ja) 1993-06-17
EP0644202B1 (de) 1997-03-05
US5922532A (en) 1999-07-13
AU9068991A (en) 1992-07-08
EP0754704A2 (de) 1997-01-22
ATE185350T1 (de) 1999-10-15
DE69029092T2 (de) 1997-04-17
DK0754704T3 (da) 2000-04-03
KR0181344B1 (ko) 1999-04-01
ATE144993T1 (de) 1996-11-15
HU9202645D0 (en) 1993-01-28
EP0644202A1 (de) 1995-03-22
HU218357B (hu) 2000-08-28
ES2101388T3 (es) 1997-07-01
CY2053B1 (en) 1998-04-30
DE69030124T2 (de) 1997-09-18
DK0644202T3 (da) 1997-09-15
ATE149522T1 (de) 1997-03-15
EP0489968A1 (de) 1992-06-17
BR9106220A (pt) 1993-03-30
DE69029092D1 (de) 1996-12-12
GR3022089T3 (en) 1997-03-31
DE69030124D1 (de) 1997-04-10
KR920703632A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
GR3022089T3 (en) Synthetic antigens for the detection of antibodies to hepatitis C virus
HUT73098A (en) Hepatitis c virus (hcv) polypeptides
FI943591A7 (fi) Synteettinen hemofilus-influenssa yhdistelmärokote
RU94024561A (ru) Иммунореактивные композиции, способ получения композиции, способы получения и обнаружения антител, набор днк, клетка-хозяин, способ получения белка
DE69232906D1 (de) Detektion des Hepatis-C Virus.
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
SG95574A1 (en) Immunoreactive antigens of hepatitia e virus
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
ATE134648T1 (de) Künstliche polypeptide und antikörper in zusammenhang mit epstein-barr-virus-nuklear- antigen
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same